- Abstract
- 1. Introduction
- 2. Materials and Methods
- 2.1. Data Set
- 2.2. HQSAR
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A100492811
Sathya Babu (Department of Bioinformatics, School of Bioengineering, SRM University) ; Thirumurthy Madhavan (Department of Bioinformatics, SRM University, SRM Nagar, Kattankulathur)
2015
English
405
KCI등재후보
학술저널
1-12(12쪽)
0
0
상세조회0
다운로드목차 (Table of Contents)
참고문헌 (Reference)
1 R. Pettipher, "Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2Cells(CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis" 55 : 2915-2931, 2012
2 K. J. Abhishek, "Three-dimensional Qsar study of 2, 4-disubstituted-phenoxy acetic acid derivatives as a Crth2 receptor antagonist : Using the K-nearest neighbor method" 3 : 147-158, 2008
3 D. Bonafoux, "Thienopyrrole acetic acids as antagonists of the CRTH2receptor" 21 : 1861-1864, 2011
4 R. Pettipher, "The roles of the prostaglandin D2receptors DP1 and CRTH2 in promoting allergic responses" 153 : 191-199, 2008
5 M. A. Avery, "Structureactivity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies" 45 : 292-303, 2002
6 T. Ulven, "Novel CRTH2 antagonists : a review of patents from 2006 to 2009" 20 : 1505-1530, 2010
7 J. Pothier, "Novel 2-(2-(benzylthio)-1H-benzo[d]imidazol-1-yl)acetic acids : Discovery and hit-to-lead evolution of a selective CRTh2 receptor antagonist chemotype" 22 : 4660-4664, 2012
8 T. W. Heritage, "Molecular hologram QSAR. In rational drug design" American Chemical Society 719 : 212-, 2000
9 A. N. Hata, "Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2" 280 : 32442-32451, 2005
10 D. A. Winker, "Holographic QSAR of benzodiazepines" 17 : 224-231, 1998
1 R. Pettipher, "Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2Cells(CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis" 55 : 2915-2931, 2012
2 K. J. Abhishek, "Three-dimensional Qsar study of 2, 4-disubstituted-phenoxy acetic acid derivatives as a Crth2 receptor antagonist : Using the K-nearest neighbor method" 3 : 147-158, 2008
3 D. Bonafoux, "Thienopyrrole acetic acids as antagonists of the CRTH2receptor" 21 : 1861-1864, 2011
4 R. Pettipher, "The roles of the prostaglandin D2receptors DP1 and CRTH2 in promoting allergic responses" 153 : 191-199, 2008
5 M. A. Avery, "Structureactivity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies" 45 : 292-303, 2002
6 T. Ulven, "Novel CRTH2 antagonists : a review of patents from 2006 to 2009" 20 : 1505-1530, 2010
7 J. Pothier, "Novel 2-(2-(benzylthio)-1H-benzo[d]imidazol-1-yl)acetic acids : Discovery and hit-to-lead evolution of a selective CRTh2 receptor antagonist chemotype" 22 : 4660-4664, 2012
8 T. W. Heritage, "Molecular hologram QSAR. In rational drug design" American Chemical Society 719 : 212-, 2000
9 A. N. Hata, "Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2" 280 : 32442-32451, 2005
10 D. A. Winker, "Holographic QSAR of benzodiazepines" 17 : 224-231, 1998
11 Tripos Sybyl, "HQSAR manual"
12 W. Tong, "Evaluation of quantitative structureactivity relationship methods for large-scale prediction of chemicals binding to the estrogen receptor" 38 : 669-677, 1998
13 T. N. Birkinshaw, "Discovery of potent CRTh2(DP2) receptor antagonists" 16 : 4287-4290, 2006
14 N. Kaila, "Discovery of isoquinolinone indole acetic acids as antagonists of chemoattractant acceptor homologous molecule expressed on Th2 Cells(CRTH2)for the treatment of allergic inflammatory diseases" 57 : 1299-1322, 2014
15 S. Crosignani, "Discovery of a new class of potent, selective, and orally bioavailable CRTH2(DP2)receptor antagonists for the treatment of allergic inflammatory diseases" 51 : 2227-2243, 2008
16 R. D. Cramer, "Comparative molecular field analysis(CoMFA), 1. Effect of shape on binding of steroids to carrier proteins" 110 : 5959-5967, 1988
17 C. L. Waller, "A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds" 44 : 758-765, 2004
A CoMFA Study of Glycogen Synthase Kinase 3 Inhibitors
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2022 | 평가예정 | 신규평가 신청대상 (신규평가) | |
2021-12-01 | 평가 | 등재후보 탈락 (계속평가) | |
2020-12-01 | 평가 | 등재후보로 하락 (재인증) | |
2017-01-01 | 평가 | 등재학술지 유지 (계속평가) | |
2013-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | |
2012-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | |
2010-01-01 | 평가 | 등재후보학술지 선정 (신규평가) |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0.45 | 0.45 | 0.35 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.28 | 0.25 | 0.24 | 0.05 |